Henlius is dedicated to addressing unmet clinical needs and collaborates with internationally renowned enterprises and research institutions to accelerate the implementation of innovative products and technologies, benefiting patients worldwide.

Currently, the company has been initiating strategic collaborations with global leading pharmaceutical companies including Accord, Abbott, Elea, Essex, FARMA DE COLOMBIA, Intas, KGbio, Organon, etc. The product licenses cover mainstream and emerging markets around the globe, reaching more than 100 countries and regions. 

Contact us: BD@henlius.com